Clovis Oncology Inc Banner Image

Clovis Oncology Inc

  • Ticker CLVS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Clovis Oncology Inc Logo Image
  • 201-500 Employees
  • Based in Boulder, Colorado
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates which include Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is in advanced clinical development for the treatment of non-smallMore cell lung cancer; Rucaparib, an oral inhibitor of poly polymerase, which is in advanced clinical development for the treatment of ovarian cancer; and Lucitanib, an oral inhibitor of the tyrosine kinase that is in Phase II development for the treatment of breast and lung cancers.
4.8 / 5.0 (265)

Clovis Oncology Inc reports have an aggregate usefulness score of 4.8 based on 265 reviews.

Clovis Oncology Inc

Most Recent Annual Report

Clovis Oncology Inc
MOST RECENT 2021 Annual Report and Form 10K

Clovis Oncology Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Clovis Oncology Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!